Kenvue Inc. logo

Kenvue Inc.

KVUE

NYSEConsumer DefensiveHousehold & Personal Products

Regular session

$19.30

+$0.24 · +1.26%

Aug 24, 1:04 PM ET

KVUE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

84

Deep Value

Momentum

49

Neutral

Sentiment

54

Mixed

Risk resilience

77

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Industry
Household & Personal Products
Sector
Consumer Defensive
Headquarters
US
CEO
Kirk L. Perry
Listed since
May 4, 2023
Employees
21,890

Market position

Day range

Current $19.30

52-week range

Current $19.30

Open
$19.17
Previous close
$19.06
Volume
7.45M
0.37× average
Average volume
20.19M
Average daily volume
Market cap
37.06B USD
Beta
0.43
Market reference 1
50-day average
$19.0244
+1.45% above average
200-day average
$17.8263
+8.27% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
40.42B USD
EV / EBITDA
13.77×
Earnings yield
4.46%
Free cash flow yield
5.23%

Profitability & efficiency

Return on equity
13.66%
Return on assets
5.43%
Return on invested capital
8.80%

Financial health

Current ratio
0.96×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends63%43%22%2%Gross margin, FY2021: 55.93%Gross margin, FY2022: 55.42%Gross margin, FY2023: 55.96%Gross margin, FY2024: 57.97%Gross margin, FY2025: 58.13%Operating margin, FY2021: 19.40%Operating margin, FY2022: 17.89%Operating margin, FY2023: 16.27%Operating margin, FY2024: 11.91%Operating margin, FY2025: 17.88%Net margin, FY2021: 13.80%Net margin, FY2022: 13.81%Net margin, FY2023: 10.77%Net margin, FY2024: 6.66%Net margin, FY2025: 9.72%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 55.93%. Gross margin FY2022 55.42%. Gross margin FY2023 55.96%. Gross margin FY2024 57.97%. Gross margin FY2025 58.13%. Operating margin FY2021 19.40%. Operating margin FY2022 17.89%. Operating margin FY2023 16.27%. Operating margin FY2024 11.91%. Operating margin FY2025 17.88%. Net margin FY2021 13.80%. Net margin FY2022 13.81%. Net margin FY2023 10.77%. Net margin FY2024 6.66%. Net margin FY2025 9.72%.

Income trends

Revenue

15.12B USD-2.14%

Operating income

2.7B USD+46.88%

Net income

1.47B USD+42.72%
Income trends across reported periods16.9B USD11.13B USD5.36B USD−412.5M USDRevenue, FY2021: 15.05B USDRevenue, FY2022: 14.95B USDRevenue, FY2023: 15.44B USDRevenue, FY2024: 15.46B USDRevenue, FY2025: 15.12B USDOperating income, FY2021: 2.92B USDOperating income, FY2022: 2.68B USDOperating income, FY2023: 2.51B USDOperating income, FY2024: 1.84B USDOperating income, FY2025: 2.7B USDNet income, FY2021: 2.08B USDNet income, FY2022: 2.06B USDNet income, FY2023: 1.66B USDNet income, FY2024: 1.03B USDNet income, FY2025: 1.47B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 15.05B USD. Revenue FY2022 14.95B USD. Revenue FY2023 15.44B USD. Revenue FY2024 15.46B USD. Revenue FY2025 15.12B USD. Operating income FY2021 2.92B USD. Operating income FY2022 2.68B USD. Operating income FY2023 2.51B USD. Operating income FY2024 1.84B USD. Operating income FY2025 2.7B USD. Net income FY2021 2.08B USD. Net income FY2022 2.06B USD. Net income FY2023 1.66B USD. Net income FY2024 1.03B USD. Net income FY2025 1.47B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue15.12B USD15.46B USD15.44B USD14.95B USD15.05B USD
Cost of goods sold6.33B USD6.5B USD6.8B USD6.67B USD6.64B USD
Gross profit8.79B USD8.96B USD8.64B USD8.29B USD8.42B USD
Research and development382M USD
Selling, general, and administrative6.09B USD6.03B USD6.14B USD5.63B USD5.48B USD
Operating expenses6.09B USD7.12B USD6.13B USD5.61B USD5.5B USD
Interest income53M USD108M USD
Interest expense379M USD431M USD358M USD
Depreciation and amortization557M USD622M USD627M USD644M USD731M USD
Operating income2.7B USD1.84B USD2.51B USD2.68B USD2.92B USD
Net income1.47B USD1.03B USD1.66B USD2.06B USD2.08B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 1 miss, 1 met estimate
Average EPS surprise
+8.66%
11 comparable reports
Latest EPS result
0.31
Estimate 0.32 · Miss by 2.73%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.360.30.250.19Q1 '25MetQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 0.26, estimate 0.26, surprise 0.00%, Met estimate. Q2 2025, reported May 8, 2025: actual 0.24, estimate 0.228, surprise +5.49%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.29, estimate 0.282, surprise +2.95%, Beat. Q4 2025, reported Nov 3, 2025: actual 0.28, estimate 0.26, surprise +7.61%, Beat. Q1 2026, reported Feb 17, 2026: actual 0.27, estimate 0.223, surprise +21.24%, Beat. Q2 2026, reported May 7, 2026: actual 0.32, estimate 0.262, surprise +22.09%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.31, estimate 0.319, surprise -2.73%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate 0.28, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates4.12B3.92B3.71B3.5BQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 3.66B USD, estimate 3.76B USD, surprise -2.61%, Miss. Q2 2025, reported May 8, 2025: actual 3.74B USD, estimate 3.68B USD, surprise +1.73%, Beat. Q3 2025, reported Aug 7, 2025: actual 3.84B USD, estimate 3.85B USD, surprise -0.36%, Miss. Q4 2025, reported Nov 3, 2025: actual 3.76B USD, estimate 3.82B USD, surprise -1.46%, Miss. Q1 2026, reported Feb 17, 2026: actual 3.78B USD, estimate 3.69B USD, surprise +2.57%, Beat. Q2 2026, reported May 7, 2026: actual 3.91B USD, estimate 3.84B USD, surprise +1.67%, Beat. Q3 2026, reported Aug 6, 2026: actual 3.96B USD, estimate 3.97B USD, surprise -0.27%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate 3.86B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

14 ratings
Strong buy00%
Buy429%
Hold1071%
Sell00%
Strong sell00%

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.825

2025 complete year+1.9% since 2024

2026 partial: $0.625

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Aug 12, 2026

$0.21

Quarterly

Record Aug 12, 2026 · Payment Aug 26, 2026

Dividend

Ex-dividend May 13, 2026

$0.2075

Quarterly

Record May 13, 2026 · Payment May 27, 2026

Dividend

Ex-dividend Feb 11, 2026

$0.2075

Quarterly

Record Feb 11, 2026 · Payment Feb 25, 2026

Dividend

Ex-dividend Nov 12, 2025

$0.2075

Quarterly

Record Nov 12, 2025 · Payment Nov 26, 2025

Dividend

Ex-dividend Aug 13, 2025

$0.2075

Quarterly

Record Aug 13, 2025 · Payment Aug 27, 2025

Dividend

Ex-dividend May 14, 2025

$0.205

Quarterly

Record May 14, 2025 · Payment May 28, 2025

KVUE peers

ETFs holding KVUE

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research KVUE

research.disclaimer